BrightPath Biotherapeutics Co., Ltd. (4594.T) JPX
Currency In JPY
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 7.7B |
| Enterprise Value | 5.54B |
| P/E Ratio | -4.14 |
| PEG Ratio | 0.48 |
| Price/Sales Ratio | 71,806.45 |
| Price/Book Ratio | 4.04 |
| Enterprise/Revenue | 46,309.29 |
| Enterprise/EBITDA | -1.79 |
Fiscal Year
| Fiscal Year | March 31, 2026 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | -25,704.4 |
| Operating Margin | -25,753.47 |
AD
Management Effectiveness
| Return On Assets | -0.79 |
| Return On Equity | -0.93 |
Income Statement
| Revenue | 84,000 |
| Revenue/Share | 0 |
| Gross Profit | 55,000 |
| EBITDA | -1.3B |
| Net Income | -1.3B |
| Diluted EPS | -11.7 |
Balance Sheet
| Total Cash | 1.58B |
| Total Cash/Share | 11.38 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 15.56 |
| Book Value Per Share | 13.12 |
Price History
| 52-Week Change | -35.37 |
| 52-Week High | 96 |
| 52-Week Low | 43 |
| Moving Average 50 Days | 48.24 |
| Moving Average 200 Days | 56.84 |
Statistics
| Average Volume | 1.37M |
| Shares Outstanding | 84M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
